Application of Amyloid PET in Cerebral Amyloid Angiopathy

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.

Also called NCT03542656

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Phase 3
Enrolled
  • 160 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03542656
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03542656. Allocation not applicable; no masking; primary purpose diagnostic. Start 2014-09-11 (actual); primary completion 2016-02-17 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Application of Amyloid PET in Cerebral Amyloid Angiopathy
Acronym
CAA
Condition
Cerebral Amyloid Angiopathy
Condition
Intracranial Hemorrhages
Condition
Alzheimer Disease
Intervention (Drug)
amyloid PET
Lead sponsor
National Taiwan University Hospital (class: other)

Record details

Record id
cardio:ct-nct03542656
Content hash
559a406d6bfdc956676629348e892500578d03e736eb4a3f9733fc8ee5ed1b4b